TEBARIN

Welcome to the Brand page for “TEBARIN”, which is offered here for Monoclonal antibody to be used in connection with systemic fibrotic disease or for ophthalmic use, to be delivered via injection or for topical use;.

Its status is currently believed to be active. Its class is unavailable. “TEBARIN” is believed to be currently owned by “CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED”.


Owner:
CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Owner Details
Description:
MONOCLONAL ANTIBODY TO BE USED IN CONNECTION WITH SYSTEMIC FIBROTIC DISEASE OR FOR OPHTHALMIC USE, TO BE DELIVERED VIA INJECTION OR FOR TOPICAL USE;
Categories: MONOCLONAL ANTIBODY BE USED